{
    "title": "112_hr3526",
    "content": "The Act is titled the \"Heart Disease Education, Analysis, Research, and Treatment for Women Act\" or the \"HEART for Women Act\". It includes a section on reporting of data in applications for drugs, biologics, and devices. The Comptroller General of the United States will conduct a study on sponsors' compliance with FDA requirements for clinical studies of drugs, biologics, and devices. A report will be submitted to relevant committees within 12 months of the Act's enactment. The report required by the Comptroller General of the United States will include a description of FDA assistance to sponsors in complying with requirements, the effectiveness of FDA enforcement, and an analysis of representation in clinical studies by gender, age, and race. The report required by the Comptroller General will analyze the availability of product safety data by gender, age, and race. The Secretary of Health and Human Services will submit recommendations for modifications to FDA requirements. The Secretary of Health and Human Services will submit a response to the report, including a corrective action plan. The Director of the Office of Women's Health of the FDA will submit biennial reports to the Committees on women's health. In this section, the Director of the Office of Minority Health will submit a report to the Committees on minority health, including elements related to biologics, devices, and drugs as defined in relevant acts. SEC. 3. REPORTING ON QUALITY OF AND ACCESS TO CARE FOR WOMEN WITH CARDIOVASCULAR DISEASES. The Secretary of Health and Human Services must submit an annual report to Congress on the quality of and access to care for women with heart disease, stroke, and other cardiovascular diseases, with recommendations for improvement. SEC. 4. EXTENSION OF WISEWOMAN PROGRAM. Section 1509 of the Public Health Service Act is amended to authorize grants to states for specific purposes and allocate funding for fiscal years 2012-2016. Additionally, a new subsection is added for a study. The Secretary will conduct a study on the impact of the Patient Protection and Affordable Care Act on preventive health services for women, with recommendations due to Congress within 18 months. The Secretary will conduct a study on the impact of the Patient Protection and Affordable Care Act on preventive health services for women, with recommendations due to Congress within 18 months. Additionally, services described in paragraph (1) will be provided to eligible women under grants funded under this section."
}